Looking to publish in Immunotherapy Advances? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowImmunotherapy Advances is an official journal of the British Society for Immunology focused on immunotherapy. It is indexed in Web of Science, PubMed Central, and Scopus, and is edited by Professor Tim Elliott with support from a global editorial board of experts from academia and industry.
Looking to publish in Immunotherapy Advances? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Immunotherapy Advances accepts the following article types. Click on an article type to view submission instructions.
Research Article
Review
Commentary
Clinical Trial Protocols
Historical Perspective
Recent Publications
NLRC5 expression within tumor cells is critical to activate adaptive and innate antitumor immune responses
Akhil Shukla, Mohammad Moradzad, Akouavi Julite Irmine Quenum, Jean-François Lucier, Anny Armas Cayarga, Dominique Lévesque, François-Michel Boisvert, Thomas A Kufer, Sheela Ramanathan, Subburaj Ilangumaran
Extracellular adenosine released by mesenchymal stromal cells from young hosts boosts the antimicrobial activity of neutrophils from aged hosts against Streptococcus pneumoniae
Rania Hassan Mohamed, Michael C Battaglia, Elsa N Bou Ghanem
Preclinical assessment of MAGE-A4-specific TCR-NK cells against solid tumors
Margherita Boieri, Justyna Kmiecik, Maja Sandve, Zara Hannoun, Martha Eimstad Haugstøyl, Inês Cardoso, Sarah Vollmers, Anja Ruppelt Oldenburg, Luz Maria Mora-Velandia, Camilla Sletten, Giulia Malachin, Artur Cieslar-Pobuda, Liliane Christ, Pimthanya Wanichawan, Dennis Clement, Michelle Lu Saetersmoen, Frida Loe Haugen, Amanda Malene Ruud, Julia Mayumi Ino, Pranav Oberoi, Anders Holm, Emilie Gauthy, Namir Jafar Hassan, Sylvie Pollmann, Luise Ullrike Weigand
Targeting intratumoral regulatory T cells by CD137 aptamer-shRNA chimeras
Kang Yi Lee, Yu Mei, Haiyan Liu, Herbert Schwarz
Comprehensive spatial and immune profiling of metastatic mismatch repair–deficient colorectal cancer reveals response to immunotherapy
Ilkyu Park, Hari Kang, Se-Hee Kim, YunJae Jung, Won-Suk Lee
Frequently asked questions
How long does it take to publish?
Accepted manuscripts are published online within 1 week in Advance Articles. The final copyedited and proofed version is published as soon as it is ready.
Reformat to Immunotherapy Advances using Livewrite PremiumIs a cover letter required?
A cover letter is expected in some cases, including when authors or co-authors do not have an institutional or affiliation-linked email address. Use of AI tools should be disclosed in cover letters to editors. Commentary submissions should include a clear reference to the original work in the cover letter.
Reformat to Immunotherapy Advances using Livewrite PremiumWhat are the publication costs?
There is usually an Article Processing Charge (APC) for fully open access journals and for gold open access in hybrid journals. Diamond OA journals publish for free.
Reformat to Immunotherapy Advances using Livewrite Premium